This study involved a comparison of activity of several long-chain fatty acids (arachidonic acid, dihomo-[r]-linolenic acid, linoleic acid, and oleic acid) for protection against gastric mucosal damage elicited by taurocholic acid, acidified aspirin, and ethanol in rats. Each damaging agent induced gastric mucosal lesions in the corpus. Mucosal damage was induced by all agents, and all fatty acids protected the gastric mucosa; however, ethanol and arachidonic acid were the most potent damaging and protecting agents, respectively. Maximally protective doses for prevention of taurocholic acid-induced damage by arachidonic, dihomo-[y]linolenic, linoleic, and oleic acids were 50,200, 100, and 200 mg/kg, respectively; however, 10 mg/kg arachidonic acid reduced lesion length by >SO%, whereas minimally effective doses of the other fatty acids were 1 5 0 mgl kg. Similar potency differences were observed for fatty acid protection against acidified aspirin-induced gastric damage. Although all the fatty acids reduced macroscopic damage, histologic studies showed they did not totally eliminate surface mucosal damage. Microscopic analysis showed that treatment with dihomo-[yl-linolenic acid or oleic acid attenuated depletion of neutral and acidic glycoproteins from the mucus neck cells of the gastric mucosa in response to exposure to taurocholic acid. Despite having similar gastroprotective activity, arachidonic, dihomo-[yl-linolenic, linoleic, and oleic acids had very dissimilar abilities to elevate gastric mucosal E-series prostaglandins. Both arachidonic and dihomo-[TI-linolenic acids elevated E-series prostaglandins, but arachidonic acid had 2-5-fold greater gastroprotective potency. Furthermore, oleic and linoleic acids, which had protective potency similar to that dihomo-[yl-linolenic acid, did not significantly elevate prostaglandins. These studies failed to demonstrate an absolute correlation between prostaglandin elevation and gastroprotection. The results of this investigation suggest that prostaglandin elevation, although associated with gastroprotection, does not appear to be the sole mechanism for fatty acid-mediated protection of rat gastric mucosa.
Vet Pathol 31: 6, 1994 observations, Oates and Hakkinen proposed a mechanism for gastric damage, in which a rapid alteration in local vascular function was a necessary initiating event in the damage process." Several reports have suggested that agents that protect the gastric mucosa can act through augmenting the hydrophobic barrier hypothesized to line the gastric mucosal surface, hence reducing mucosal exposure of strong Observations that exogenous administration of PG biosynthetic precursor fatty acids (arachidonic acid [AA] and linoleic acid [LA] ) but not of oleic acid (OA) elevated gastric PGs and protected rat gastric mucosa from ethanol damage, provided an interesting correlate t o the concept that PGs mediated gastroprotection. AA was also reported t o prevent aspirin-induced mucosal injury. 34 Similar studies described herein have provided further evaluation of fatty acid mediated gastroprotection in rats. W e observed that PG precursor fatty acids protected against ethanol injury and against damage induced by acidified aspirin and taurocholic acid. However, OA was also gastroprotective, having a potency equivalent t o LA or dihomo-[yl-linolenic acid (DHGL, precursor of PGE,) . W e previously reported that although AA and DHGL significantly elevated E-series PGs recoverable from the gastric luminal contents of rats, LA and OA failed t o have the same effect.2 Because LA and OA had gastroprotective efficacy equivalent to that of DHGL, yet had much less of an effect on elevating gastric PGs, the mechanistic basis for fatty acid-mediated gastroprotection appeared to be more complex than originally proposed. 
Materials and Methods

Animals and materials
Male CD strain rats (Charles River, 175-200 g) were used in all studies. Rats were individually housed in mesh-bottom cages to limit coprophagy and were fasted for 16-24 hours prior to experimentation, with water removed for the last 4 hours. Fatty acids (Sigma Chemical Co., St. Louis, MO, or Nu-Chek Prep Labs, Elysian, MN) were solubilized in 5 mm F-68 Pluronic (PF-68; BASF Wyandotte Corp., Parsippany, NJ) in aqueous solution, and the pH adjusted to 8.0 -t 0.1 with NaOH. All fatty acid solutions were prepared immediately prior to use.
Gastric damage studies
Gastroprotection studies measured effects of peroral fatty acid pretreatments on gastric mucosal injury produced by subsequent peroral challenge with taurocholic acid, acidified aspirin, or ethan01.".'~J~ Following an overnight fast, rats first receive (via gastric gavage) a single dose of a fatty acid emulsion or the dosing vehicle for control studies. Fatty acids are dosed in a volume of 2.5 ml/kg. For dose-response studies, AA was administered at doses of 10, 20, 50, and 100 mglkg, and DHGL, LA, and OA at doses of 20,50, 100, and 200 mg/kg. Thirty minutes following fatty acid dosing, rats were administered one of the following agents (via gastric gavage): 100% ethanol (1 0 ml/kg), acidified aspirin (5 ml/kg of a 25 mglml acetylsalicylic acid in 0.2 N HCI), or taurocholic acid (10 ml/kg of 0.1 M taurocholic acid in 0.2 N HCI). Hence, a 250-g rat would receive 2.5 ml 100% ethanol, 1.25 ml of the acidified aspirin suspension (providing an equivalent of 125 mg/kg acetylsalicylic acid in 0.2 N HCl), or 2.5 ml 0.1 M taurocholic acid in 0.2 N HCl. One hour after receiving ethanol or taurocholic acid or 2 hours after receiving acidified aspirin, rats were euthanatized. Their stomachs were immediately removed and opened along the greater curvature, and a macroscopic estimate of gastric mucosal injury was determined by measuring the total length (in millimeters) of formed lesions using a dissection microscope fitted with an eyepiece reticule. Macroscopic injury appeared very similar to that previously described. 22 Injury consisted of red to black mucosal erosions of various lengths, usually oriented parallel to the longitudinal axis of the stomach. Multiple lesions were usually observed, and the lesion lengths reported in the figures and tables represent the mean total for macroscopic lesions in a treatment group. To prevent bias, dosing solutions were coded and dosing sequences randomized, and individuals measuring gastric lesion length were unaware of treatments.
Histology
Histologic evaluations were conducted on rats treated with 0.1 M taurocholic acid or vehicle alone and on rats that received 100 mg/kg DHGL and 200 mg/kg OA 30 minutes prior to taurocholate or vehicle treatment. Rats were euthanatized 1 hour after receiving taurocholic acid. Immediately following euthanasia, stomachs were removed, the esophagus was ligated, and 10 ml of 10% normal buffered formalin was instilled into the gastric lumen through the pylorus. The pylorus was ligated, and the stomach was placed into 10% normal buffered formalin. After 18 hours of fixation, the stomachs were opened along the greater curvature and sampled for histologic preparation. For each group, at least four independent samples were taken from the glandular portion of the stomachs, extending from the limiting ridge toward the pylorus for a distance of 2-3 cm. Specimens were dehydrated through a graded series ofalcohols and embedded in paraffin. Sections 4-6 prn thick were stained with hematoxylin and eosin (HE) for morphologic analyses. Morphometric analysis of HE-stained sections was conducted in a coded and randomly stratified fashion in which the reviewer had no information on treatment sequence. The evaluation process consisted of serial measurement at 60-1 00-hm intervals of the mucosal thickness extending from the propria muscularis mucosa to the luminal surface of the epithelial cells. Mucosal thickness was used to evaluate depth of mucosal injury. No less than five measurements were made for each histologic sample. Additionally, pathologic evaluation was conducted to determine treatment-associated lesions.
Histochemical evaluation for gastric mucosal glycoproteins
Formalin-fixed, paraffin-embedded tissue sections were used for both Alcian blue and periodic acid-Schiff (PAS) Vet Pathol 3 1:6, I994 Fatty Acid-mediated Gastroprotection histochemical evaluation. Alcian blue staining was used at pH 2.5 to identify acidic mucins and acid mucosubstances in gastric mucus. Both carboxylated and sulfated acidic mucosubstances and mucins are stained at this pH. The PAS reaction was used to demonstrate neutral mucosubstances. Histochemical identification of gastric mucosal glycoprotein content was graded on a scale of 0 to 4, with 4 being the most intense staining reaction.
Measurement of prostaglandins
Development and validation of the methodologies used to extract and isolate PGs from gastric lumenal contents and for quantitation by specific radioimmunoassay have been fully described elsewhere., Ten minutes after intragastric administration of vehicle (for controls), AA, DHGL, LA, or OA (2.5 ml/kg, prepared as described above), animals were euthanized and their stomachs were immediately removed. Gastric contents were collected on ice, and the stomach lumen was rinsed with saline. The gastric contents and saline rinse from each stomach were combined, acidified to pH 3.5 with HC1, and extracted using ethyl acetate. After drying under N,, the extract residue was resuspended in a minimal volume of ethyl acetate and chromatographed on silica thin layer chromatography plates using a solvent system (ethyl acetatehso-octane/acetic acid/water, 65/25/ 10/50; upper phase), which resolved PGs from contaminating fatty acids (R, > 2.0). Silica gel corresponding to the PG region of the plates was removed and twice extracted in ethyl acetate, and the supernatant was taken to dryness under N,. The efficiency for recovery of PGs from gastric fluid, assessed by inclusion of trace levels of l4C-1abeled PGs, was 47.4 k 7.3%. The separation efficiency for the TLC purification of PGs against each of the fatty acids was validated using a highly sensitive G U M S technique., After reconstitution in a phosphate buffer system, PGE, and PGE, were determined by specific radioimmunoassay (RIA). RIAs used commercially available systems (Seragen, Boston, MA, and New England Nuclear, Boston, MA) for determination of PGE, and PGE, immunoreactivity, respectively. The antibodies provided were highly specific for their selective PG, and cross-reactivity with free fatty acids (i.e.> AA, DHGL, etc.) was less than 0.001%.
Statistical analysis
Comparisons between control and treatment were done using Student's t-test. For an individual damage model, doseresponse relationships were compared to determine significant differences in fatty acid potency by analysis of variance (ANOVA) and analysis of covariance interaction tests. Differences were considered significant at P 5 0.05.
Results
Oral dosing of ethanol, acidified aspirin, or taurocholic acid rapidly resulted in appearance of mucosal lesions. Injury from all three damaging agents was oriented along the longitudinal axis of the stomach and was confined to the corpus region (data not shown). Although lesions induced by taurocholic acid and aspirin appeared sharply etched into the mucosal surface, damage from ethanol treatment was similar to that reported previously, having a wider and less etched a p p e a r a n~e .~~.~~ Extent of damage, measured as total lesion length, was highly dependent upon the damaging agent. The mean (+ SEM) of gastric lesion lengths in the absence of fatty acid pretreatment was 45.8 f 7.6 mm ( n = 90), 66.4 -t 8.0 mm ( n = 87), and 221.7 5 17.6 mm (n = 40) for damage in response to acidified aspirin, taurocholic acid, and ethanol, respectively.
Effects of fatty acids on taurocholic acid-induced gastric damage
AA (Fig. lA) , DHGL ( Fig. lB) , LA (Fig. lC) , and OA ( Fig. 1 D) dose-dependently protected against gastric injury in response to 0.1 M taurocholic acid. Though not shown in Fig. 1, 10 mg/kg AA also protected against taurocholate-induced injury, reducing gross mucosal damage (measured as lesion length) 58%, from 63.6 -t 8.4 mm ( n = 18) to 26.7 k 10.0 mm (n = 10) (P < 0.05). AA was significantly more potent (P < 0.05) than DHGL, LA, or OA. Minimal and maximal protective doses were I 10, 50, 50, and 100, and 50, 200, 100, and 200 mg/kg for AA, DHGL, LA, and OA, respectively. Furthermore, although a maximal level of gastroprotection was obtained with each fatty acid, some macroscopic mucosal damage remained detectable. Thus, none of the fatty acids provided complete protection against lesion formation in this damage model. Both LA and DHG!, were significantly more potent than OA for protectin$ against gastric injury by taurocholic acid (P < 0.05, AWOVA).
Histologic evaluation of mucosal damage induced by taurocholic acid and protection by DHGL and OA
By gross measurement of gastric damage, DHGL and OA appeared to have similar gastroprotective potency. However, only DHGL is a direct synthetic precursor for cyclooxygenase conversion to form PGs. Furthermore, although gastroprotective doses of PGprecursor fatty acids have been reported to elevate gastric lumenal PGs, OA did Therefore, because of similar gastroprotective action but dissimilar effects on PG production, we chose to further compare protection by DHGL and OA histologically.
As compared with vehicle (PF-68 alone)-treated controls, taurocholic acid induced epithelial cell degeneration and necrosis and formation of multiple focal superficial ulcers ( Fig. 2A, B) . In contrast to results in tissues treated with taurocholic acid alone, histologic evaluation of tissues pretreated with 100 mg/kg DHGL or 200 mg/kg OA (administered 30 minutes prior to taurocholic acid challenge) showed fatty acid pretreat-ment afforded significant protection. Both DHGL (not shown) and OA (Fig. 2C ) equivalently reduced the severity of taurocholic acid-induced mucosal damage and degeneration. Despite the presence of histologic change, exposure to taurocholic acid alone did not significantly effect overall mucosal thickness (Table 1) . Taurocholic acid treatment, however, dramatically altered mucosal neutral and acidic glycoprotein content, with the most severe changes occurring to the surface and mucus neck cells (see Fig. 3 ). Taurocholic acid treatment also reduced both neutral and acidic glycoprotein content in ulcerated regions (Table 1 . Fig. 3A-D) . In contrast, protection by 100 mg/kg DHGL (Fig. 3E, F (Fig. 4A) , DHGL (Fig. 4B) , LA (Fig. 4C) , and OA (Fig. 4D ) also dose-dependently inhibited formation of gastric mucosal lesions induced by exposure to 125 mg/kg acidified aspirin. Minimal and maximal gastroprotective doses protecting against acidified aspirin were 20, 50, 50, and 200, and 50, 200, 200, and 200 mg/kg for AA, DHGL, LA, and OA, respectively. Hence, though AA was fourfold more potent than DHGL, LA, and OA (P < 0.05, ANOVA), potencies of the other fatty acids were not significantly different. In addition, and as observed with taurocholic acid, at maximal effective doses, fatty acids did not completely prevent lesion formation in response to acidified aspirin challenge.
DHGL and OA-mediated protection against mucosal injury by ethanol
DHGL and OA dose-dependently protected rat gastric mucosa from ethanol damage (Fig. 5 ) . DHGL was significantly more potent than OA ( P < 0.05, ANO-VA); however, this was solely due to a difference at the 100 mg/kg dose. These results represented data pooled from two experiments. Although DHGL at 50 and 100 mg/kg remained equally gastroprotective against ethanol-induced damage in both experiments, reducing lesion formation 40-45% and 67-6S0/0 respectively, this reproducibility was not observed for OA (Table 2) . At 50 mg/kg, OA efficacy was equivalent to that of DHGL in both trials, reducing lesion length by 41%; however, at the 100 mg/kg dose, OA reduced ethanol damage (by 55%) in only one experiment. In the second study, 100 mg/kg OA was not significantly protective.
Effect of long chain fatty acids on gastric PG concentrations
The protection studies suggested that gastroprotection by AA, DHGL, LA, and OA would not appear to correlate with their ability to serve as direct biosynthetic precursors of PG synthesis. To address this directly, we compared the ability of these agents to elevate gastric E-series PGs. A previous study reported, DHGL Table 3) . Although we observed a small (approximately fivefold) elevation in PGE, in response to OA, this elevation could not be attributed to direct conversion of OA to PGs and may have represented an irritancy effect of dosing fatty acid emulsions.
Discussion
Pretreatment with PG and other cytoprotective agents is well known to reduce the degree of macroscopic damage subsequent to chemical insult. However, these agents do not completely prevent histologic changes associated with tissue damage, because some loss of mucosal integrity, epithelial cell sloughing, and reduction in glycoprotein content remain even in the presence of gastroprotective agents. 6.'3.'7'L8,20,28,3L,38,41 Although there is clear demonstration, both in animals and humans, that PGs are gastroprotective, the mechanism for PG-mediated protection is not completely understood',4,7J3J6,20,21,23,26,36 nor have all studies supported a direct association between PG elevation and p r o t e~t i o n .~,~J~,~~ In a recent study in rats, no association was found between gastroprotection afforded by sulfhydryl agents or metal salts and their abilities to stimulate PG synthesis.I9 Most of the protective agents examined inhibited PG production, hence demonstrating gastroprotection occurring in the absence PG elevation. Similarly, elevation of PGs alone is not necessarily associated with gastroprotection. In one study, although somatostatin stimulated production of PGE, and 6-ketoPGFI, it failed to protect rat gastric epithelial cells grown in monolayer culture from damage in response to taurocholic acid or i n d o m e t h a~i n .~~
The present study compared gastroprotection by four essential dietary fatty acids in three models of gastric damage. AA, DHGL, and LA are synthetic precursors for PG synthesis, and OA is Our findings showed all four fatty acids dose-dependently protected rat gas- tric mucosa, with protection being independent of the damaging agent. Using lesion length as a macroscopic measure of damage, AA was consistently 4-1 0-fold more potent than DHGL, LA, or OA for preventing damage induced by taurocholic acid or acidified aspirin. Additionally, in a preliminary study we also observed that AA was more potent than DHGL, LA, and OA in preventing lesion formation in response to subsequent ethanol exposure (K. Mandel, unpublished observations); this finding agreed with that of an earlier
In contrast, the minimal differences in gastroprotective potencies observed among DHGL, LA, and OA may have simply reflected experimental variation (see Table 2 ). Although in the present study macroscopic damage was measured solely as lesion length, this approach provided an adequate, semiquantitative estimate of macroscopic damage, which likely underestimated total lesion area. Based on the lesion length measurement, our results demonstrated dose dependencies among the tested fatty acids. Hence, this approach provided an adequate measure of macroscopic damage, especially when accompanied with histology. Because other macroscopic observations measurements (i.e., lesion number, area, or index) could not replace a histologic evaluation, they would add little information over that obtained by measurement of lesion length alone.
Histologic evaluation focused solely on the action of DHGL and OA against taurocholic acid-induced damage. DHGL and OA were selected to compare actions of two fatty acids with similar gastroprotective potencies but different effects on gastric PG production. Histologic evaluation confirmed the macroscopic observations and did not demonstrate differences between the two fatty acids either in preventing microscopic injury or retaining gastric mucins. Taurocholic acid treatment alone disrupted and altered the appearance of the surface epithelium and mucosa, formed focal sites of severe mucosal damage that penetrated the mucosa, and depleted epithelial cell mucins. Pretreatment with DHGL and OA prevented formation of deep ulcerations, preserved epithelial and mucus neck cells, and dramatically reduced loss of neutral and acidic glycoprotein content from gastric epithelial and mucus neck cells. Although they reduced gross lesion formation, the fatty acid pretreatments failed to completely prevent microscopic changes. Hence, DHGL and OA limited but did not completely prevent taurocholic acid-induced histologic changes. Previous studies by others provided histologic evaluation of AA and LA treatment on protection against ethanol-induced gastric damage. Similar to our findings, AA and LA prevented ethanol-induced formation of hemorrhagic lesions and protected the surface e p i t h e l i~m . '~.~~ Although taurocholic acid alone reduced glycoprotein content, it failed to significantly alter mucosal thickness. The lack of effect on mucosal thickness suggested that these studies evaluated the gastroprotective role of DHGL and OA rather than their ability to modify ulcer development. The relationship between gastric mucosal damage models and ulcer disease remains poorly understood, and it is more likely that these models represent exaggeration of an irritation process rather than a model of ulcer disease.'
A major difference between our results and those of earlier reports10,30,33,34 was the observation of gastroprotection by OA. This observation was particularly important because even at its maximally gastroprotective dose, OA only elevated PGs about fivefold. Although similar to effects of LA, which in our study also had little effect on PG levels, effects of OA contrasted with those of DHGL, where maximally gastroprotective doses elevated PGE, over 50-fold. However, despite a l 0-fold superiority elevating gastric PGs, DHGL and OA had similar gastroprotective potency (no more than twofold difference). In contrast, despite similar effects on PG elevation, AA was significantly more potent than DHGL for preventing gastric damage in response to either taurocholic acid or acidified aspirin. Because E-series PGs have similar gastroprotective potency, it was highly unlikely that differences in potency for long-chain fatty acids reflected elevation of PGE, versus PGE2.20 Conversely, if PG elevation alone were the primary requirement for gastroprotection, AA and DHGL should have had equivalent and greater potencies than LA and OA. This relationship was not observed. Hence, the lack of correlation between gastroprotective potencies and effects on PG elevation supported a conclusion that PG elevation was not the sole mechanism by which these fatty acids mediate gastroprotection.
As reported in an earlier study, gastroprotection by fatty acids was dependent upon the presence of surfactant in the dosing matrix. In contrast, however, although 100 mg/kg DHGL in aqueous solution (no exogenous surfactant) lacked gastroprotective efficacy, it elevated gastric PGs to equivalent levels and with the same time course as when administered as the PF-68 surfactant-containing matrix2 Gastroprotection by direct administration of E-series PGs had no requirement for surfactant in the matrix,20 suggesting that other mechanisms, independent of gastric PG elevation may be involved in protection mediated by long-chain fatty acids.
Clearly the major mechanisms by which fatty acids protect rat gastric mucosa remain to be established.
The need to further investigate these mechanisms is emphasized by the observal.ion that AA was a significantly more potent gastroprotective agent than DHGL, yet both fatty acids similarly elevated gastric PGE levels. Studies using cultured rat gastric mucosal cells reported AA stimulated PG and mucus production; however, the effects of other fatty acids were not evaluated. 37 The studies reported herein suggested OA and DHGL reduced the extent of glycoprotein depletion subsequent to taurocholic acid exposure. Whether this represented preserving preformed glycoproteins or stim-Vet Pathol 31: 6, 1994 Fatty Acid-mediated Gastroprotection 687 ulation of synthesis is not known. The mechanistic basis of such events and their relation to the difference in the potency of AA remain to be determined. Other studies have reported that surface active agents, such as phospholipids, are gastroprotective and have hypothesized that these agents act to maintain integrity of a hydrophobic barrier that overlays the gastric mucosa.3~9J5~39,40 Such interactions may, at least in part, explain gastroprotective efficacy observed for fatty acids. This hypothesis is particularly supported by our histologic observation that OA and DHGL increased glycoprotein content of surface epithelial cells as compared with that of tissues treated with taurocholic acid alone. This finding also suggested that some amount of mucus production, accompanied by even small changes in PGE levels, may combine to afford gastroprotection. Additionally, this may explain our observation that LA, although gastroprotective, failed to significantly elevate gastric lumenal PG levels. LA requires extensive intracellular metabolism for cyclooxygenase-catalyzed conversion to PGs, sharply contrasting the limited metabolism required for AA and DHGL.30 Perhaps the short time course used in these studies was insufficient to allow conversion of LA to PGs. Rats fed an LA-enriched diet for 8-10 weeks had elevated PG production and reduced mucosal injury in response to cold-restraint stress.*' Furthermore, a study in humans reported that 14-20 days of treatment with elevated levels of dietary LA also increased gastric lumenal PGE levels sufficiently to inhibit basal gastric acid o u t p~t .~
